Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system

Pathology International

Volumn 60, Issue 1, 2010, Pages 1-8

  Miyamoto, Hiroshi ^a,b   Miller, Jeremy S ^b   Fajardo, Daniel A ^b   Lee, Thomas K ^b   Netto, George J ^b   Epstein, Jonathan I ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Grading; Progression; Recurrence; Urinary bladder; Urothelial neoplasm; WHO ISUP classification

Indexed keywords

BLADDER TUMOR; CANCER GRADING; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; REVIEW; UROGENITAL TRACT CANCER; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

CARCINOMA, PAPILLARY; DISEASE PROGRESSION; HUMANS; URINARY BLADDER NEOPLASMS; UROTHELIUM; WORLD HEALTH ORGANIZATION;

EID: 73649140997     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02477.x     Document Type: Review

References (46)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009 59 : 225 249.
2. Mostofi FK, Sobin LH, Torloni H. Histological Typing of Urinary Bladder Tumours. International Classification of Tumours 10. Geneva : World Health Organization, 1973.
3. Epstein JI. The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: Is it an improvement? Crit Rev Oncol Hematol 2003 47 : 83 9.
4. Abel PD, Henderson D, Bennett MK, Hall RR, Williams G. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br J Urol 1988 62 : 339 343.
5. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasm of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 12 : 1435 1448.
6. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon : IARC Press, 2004.
7. Cheng L, Bostwick DG. World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors. Cancer 2000 88 : 1513 1516.
8. Billis A, Carvalho RB, Mattos AC et al. Tumor grade heterogeneity in urothelial bladder carcinoma: Proposal of a system using combined numbers. Scand J Urol Nephrol 2001 35 : 275 279.
9. Bircan S, Candir O, Serel TA. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma. Urol Int 2004 73 : 201 208.
10. Samartunga H, Makarov DV, Epstein JI. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 2002 60 : 315 319.
11. Genega EM, Kapali M, Torres-Quinones M et al. Impact of the 1998 World Health Organization/ International Society of Urological Pathology classification system for urothelial neoplasms of the kidney. Mod Pathol 2005 18 : 11 8.
12. Pich A, Chiusa L, Formiconi A et al. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. Am J Surg Pathol 2001 25 : 1528 1533.
13. Gönül II, Poyraz A, Ünsal Ç, Acar C, Alkibay T. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases. Urol Int 2007 78 : 338 344.
14. Burger M, Denzinger S, Wieland W-F et al. Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset? BJU Int 2008 102 : 194 197.
15. Oosterhuis JWA, Schapers RFM, Janssen-Heijnen MLG et al. Histological grading of papillary urothelial carcinoma of the bladder. J Clin Pathol 2002 55 : 900 905.
16. Ramos D, Navarro S, Villamón R, Gil-Salom M, Llombart-Bosch A. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder. Cancer 2003 97 : 1876 1883.
17. Yorukoglu K, Tuna B, Dikicioglu E et al. Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder. Virchows Arch 2003 443 : 734 740.
18. Holmäng S, Andius P, Hedelin H et al. Stage progression in Ta papillary urothelial tumors: Relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 2001 165 : 1124 1128, discussion 1128 1130.
19. Lee TK, Miyamoto H, Miller JS, Fajardo DA, Netto GJ. Papillary urothelial neoplasm of low malignant potential (PUNLMP): Outcome analysis. Mod Pathol 2009 22 (Suppl 1 178A.
20. Miyamoto H, Brimo F, Schultz L et al. Low-grade papillary urothelial carcinoma of the urinary bladder: Clinicopathologic analysis in a post-WHO/ISUP classification cohort from a single academic center. Arch Pathol Lab Med 2010 in press.
21. Mostofi FK. Pathological aspects and spread of carcinoma of the bladder. JAMA 1968 206 : 1764 1769.
22. MacLennan GT, Kirkali Z, Cheng L. Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol 2007 51 : 889 898.
23. Murphy WM, Takezawa K, Maruniak NA. Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic pathology classification of urothelial neoplasms: Practical choices for patient care. J Urol 2002 168 : 968 972.
24. Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI. Urothelial neoplasms in patients 20 years or younger: A clinicopathological analysis using the World Health Organization 2004 bladder consensus classification. J Urol 2005 174 : 1976 1980.
25. Herr HW, Donat SM, Reuter VE. Management of low grade papillary bladder tumors. J Urol 2007 178 : 1201 1205.
26. Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. Mod Pathol 2001 14 : 267 272.
27. Pich A, Chiusa L, Formiconi A et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 2002 95 : 784 790.
28. Campbell PA, Conrad RJ, Campbell CM, Nicol DL, MacTaggart P. Papillary urothelial neoplasm of low malignant potential: Reliability of diagnosis and outcome. BJU Int 2004 93 : 1228 1231.
29. Yin H, Leong AS-Y. Histologic grading of noninvasive papillary urothelial tumors. Validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am J Clin Pathol 2004 121 : 679 687.
30. Desai S, Lim SD, Jimenez RE et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod Pathol 2000 13 : 1315 1323.
31. Magi-Galluzzi C, Epstein JI. Urothelial papilloma of the bladder. Am J Surg Pathol 2004 28 : 1615 1620.
32. Miller JS, Fajardo DA, Lee TK, Miyamoto H, Netto GJ. High-grade non invasive papillary urothelial carcinoma of the urinary bladder: Clinical outcome in a single academic center cohort. Mod Pathol 2009 22 (Suppl 1 183A.
33. Cheng L, Neumann RM, Bostwick DG. Papillary urothelial neoplasms of low malignant potential: Clinical and biologic implications. Cancer 1999 86 : 2102 2108.
34. McKenney JK, Amin MB, Young RH. Urothelial (transitional cell) papilloma of the urinary bladder: A clinicopathologic study of 26 cases. Mod Pathol 2003 16 : 623 629.
35. Fujii Y, Kawakami S, Koga F, Nemoto T, Kihara K. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 2003 92 : 559 562.
36. Lopez-Beltran A, Montironi R. Non-invasive urothelial neoplasms: According to the most recent WHO classification. Eur Urol 2004 46 : 170 176.
37. Oosterlinck W, Solsona E, Akaza H et al. Low-grade Ta (noninvasive) urothelial carcinoma of the bladder. Urology 2005 66 (Suppl 6A 75 89.
38. Dalbagni G. The management of superficial bladder cancer. Nat Clin Pract Urol 2007 4 : 254 260.
39. Sylvester RJ, van der Meijden A, Witjes JA et al. High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 2005 65 (Suppl 6A 90 107. (Pubitemid 43049611)
40. Holmäng S, Heldelin H, Anderström C et al. Recurrence and progression in low grade papillary urothelial tumors. J Urol 1999 162 : 702 707.
41. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000 163 : 73 8.
42. Ali-El-Dein B, Sarhan O, Hinev A et al. Superficial bladder tumours: Analysis of prognostic factors and construction of a predictive index. BJU Int 2003 92 : 393 399.
43. Fontana D, Bellina M, Scoffone C et al. Evaluation of c-ras oncogene product (p21) in superficial bladder cancer. Eur Urol 1996 29 : 470 476.
44. Crew JP, O'Brien T, Bicknell R et al. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol 1999 161 : 799 804.
45. Choi YD, Cho NH, Ahn HS et al. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma. J Urol 2007 177 : 1174 1178.
46. Hernandez S, López-Knowles E, Lloreta J et al. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J Clin Oncol 2006 24 : 3664 3671.